Innovating Works

H2020

Cerrada
HORIZON-EIC-2022-TRANSITIONOPEN-01
EIC Transition Open 2022
Expected Impact:At the end of the EIC Transition project, it should be ready for the next stage, which can be to apply for EIC Accelerator (if you are a SME, including start-ups or spin-offs), to seek other investors or sources of funding, to enter licensing or collaboration agreements with third parties, or other routes to market deployment. In case the project is not led by an SME or commercial partner, the formation and spin out of a new company can be included as part of the activities. It will be expected to describe the intended pathway and route to market in the proposal, and to specify milestones and KPIs during the implementation of your project to assess progress towards the market.
Sólo fondo perdido 100%
Europeo
Mostrando 161 al 180 de 328 resultados
Vision - Augmented Reality Windshield Display: Next Generation Augmented Reality technology to improve car safety and driving experience EYELIGHTS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Problem: Every 40s 1 driver is killed due to smartphone use while driving. Around the world, distracted driving leads to the death of 1.4 mi...
2023-01-20 - 2025-01-31 | Financiado
ArtPlac: Artificial Placenta (ArtPlac) - Miniaturized Integrated Lung and Kidney Support for Critically Ill N... KLINIKUM NURNBERG tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 This Pathfinder project will establish a radical change in the treatment of newborns using an artificial placenta (ArtPlac). What drives us...
2023-01-19 - 2027-03-31 | Financiado
HyperTargIPS-NK: Hyper-targeting CAR NK cells from induced pluripotent stem cells for novel off-the-shelf anti-tumor... AMNIOTICS AB tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 The HyperTargIPS-NK project aims to combine novel technologies from three research laboratories and a stem cell company to develop a revolut...
2023-01-19 - 2026-03-31 | Financiado
BeeOimpact: From Bees as a Service (BaaS) to Software as a Service (SaaS) to enhance biodiversity and reduce pol... BEEODIVERSITY tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 BeeOimpact platform (incl. BeeOmonitoring and BeeOgarden mobile app) is a unique SaaS solution using the bee ecosystem to extract valuable b...
2023-01-18 - 2024-12-31 | Financiado
NonInvasive Cortical Bone Microstructure Analysis: A Health Technology Assessment of a breakthrough technology in the early diagnosis of Osteoporosis a... POROUS GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Osteoporosis accounts for more days in the hospital than breast cancer, heart attack, and diabetes, leading to huge healthcare costs. Despit...
2023-01-13 - 2025-04-30 | Financiado
DYRA: Dynamic High-Performance Open Radio Access Network Technology XELERA TECHNOLOGIES GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Future 5G Radio Access Networks (RANs) are built of virtualised software modules and COTS server hardware. To meet the stringent data throug...
2023-01-11 - 2024-12-31 | Financiado
HighLine: Fine Line Dispensing Process to apply Narrow Metal Contacts onto Solar Cells HIGHLINE TECHNOLOGY GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 HighLine Technology GmbH is a ISE spin-off from Fraunhofer Institute for Solar Energy Systems with exclusive IP rights to redefine the stand...
2023-01-11 - 2025-01-31 | Financiado
SSB2: Surgify Safety Burrs for safer bone surgery SURGIFY MEDICAL OY tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 6 out of 15 top surgical procedures include bone cutting, which are performed using surgical power tools such as high-speed drills. These dr...
2023-01-11 - 2024-08-31 | Financiado
Live-Mirror: ULTRA-LIGHT, SELF-CORRECTING, LIVE MIRRORS: Lowering the areal density of mirrors and maximizing per... CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 We propose to develop ultralight, self-correcting mirrors for use in the next generation of large optical telescopes and solar energy concen...
2023-01-11 - 2027-01-31 | Financiado
4D-NMR: Single Molecule Nuclear Magnetic Resonance Microscopy for Complex Spin Systems UNIVERSITAT LINZ tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 Nanotechnology is emerging as a key area to address global challenges in health, energy, environment and information technologies. However,...
2023-01-10 - 2026-03-31 | Financiado
3DSecret: 3D spheroids derived from single cells for discovering stochastic patterns behind metastasis INTERNATIONAL IBERIAN NANOTECHNOLOGY LABORATORY tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 Metastasis remains accountable for 9 out of 10 fatalities within cancer disease. However, the mechanisms governing the onset of metastasis a...
2023-01-01 - 2026-12-31 | Financiado
ASTEASIER: Novel and sustainable biotechnological approaches for astaxanthin and ketocarotenoids production UNIVERSITA DEGLI STUDI DI VERONA tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 Microalgae are photosynthetic unicellular microorganisms which can be cultivated at industrial level and adopted as sustainable platforms to...
2023-01-01 - 2024-12-31 | Financiado
SuperClean: Superhydrophobic membranes for clean water production NATIONAL CENTER FOR SCIENTIFIC RESEARCH DEMOKRITOS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-TRANSITION-01 Our world faces an urgent need for a greener industry with reduced water consumption and zero pollution, alleviating water scarcity problems...
2023-01-01 - 2025-12-31 | Financiado
DARkWIN: Pollinator-assisted plant natural selection and breeding under climate change pressure AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 Food security is threatened by climate change, with heat and drought being the main stresses affecting crop physiology and ecosystem service...
2022-12-27 - 2026-06-30 | Financiado
THOR: building vascular networks and Blood-Brain-Barriers through a Biomimetic manufacturing Technology fo... UNIVERSIDAD POLITÉCNICA DE MADRID tramitó un HORIZON EUROPE: HORIZON-EIC-2022-PATHFINDEROPEN-01 Tenths of millions of people with organ failures or suffering from degenerative diseases are waiting for a novel cellular therapy or for a t...
2022-12-22 - 2026-12-31 | Financiado
Aviwell: Development and validation of Direct-Fed Microbials for farm animals to improve animal growth and be... CENTRE DE RECHERCHE ET DE DEVELOPPEMENT DES ANATIDES DU COURTALET tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 In 2021, the worldwide population was approximately 8B, and it is expected to grow at >1% annually. Over the past 70 years, the agriculture...
2022-12-21 - 2025-11-30 | Financiado
PARAGON NOVEL VACCINE: Paragon Novel Vaccine (PNV) an effective protection against all serotypes of five deadly bacteria to... IMMUNETHEP tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Immunethep has developed, patented (WO/2015/189422), and successfully undergone preclinical trials for a new breakthrough vaccine (PNV-Parag...
2022-12-21 - 2025-06-30 | Financiado
BlinkIn Visual Assistant - June 2021: "BlinkIn Visual Assistance - Defining a new category of automated visual support towards to a visual... BLINKIN GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 BlinkIn develops a platform to enable the next generation of tech support. Tech support is with BlinkIn visual and automated. BlinkIn enable...
2022-12-21 - 2025-01-31 | Financiado
FarmInsect: Automated turnkey insect rearing farm. Enabling farmers to produce their own sustainable insect prot... FARMINSECT GMBH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 FarmInsect responds to the global need for alternative protein sources for animal feed in a sustainable and efficient way for farmers. FarmI...
2022-12-21 - 2024-12-31 | Financiado
fight-dm1: First In class oliGo THerapy for Myotonic Dystrophy type 1 (DM1) ARTHEX BIOTECH tramitó un HORIZON EUROPE: HORIZON-EIC-2022-ACCELERATOR-01 Myotonic dystrophy type 1 (DM1) is a clinically and genetically heterogeneous disorder with more than 1 million diagnosed patients worldwide...
2022-12-21 - 2025-06-30 | Financiado